Funding will accelerate development of first-in-class small-molecule drugs for a condition with no approved targeted ...

Families living with Noonan Syndrome say there is a pressing need for more social support and awareness of the rare genetic condition. Loughborough University researchers have spoken with more than 60 ...

Novo Nordisk reported positive data from a late-stage trial of its once-weekly Sogroya treatment for children with growth disorders. The Danish pharmaceutical giant said the drug was more effective ...

Sevenless Therapeutics Ltd. has patented son of sevenless homolog 1 (SOS1) inhibitors reported to be useful for the treatment of cancer, pain, dementia, Noonan syndrome, parkinsonism, ...

To the best of our knowledge, there have been no previously published reports in the medical literature of phytobezoars in patients with Noonan syndrome. This case represents what may be an ...